Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 September 2021 | Story Nonsindiso Qwabe | Photo Supplied
Dr Samantha Potgieter.

As COVID-19 vaccines continue to be a topical issue in South Africa and indeed in the world itself, the Department of Human Resources held a webinar for the UFS community on 10 September that delved deeper into the questions surrounding the vaccine. 

Dr Samantha Potgieter, infectious disease expert at the Universitas Academic Hospital and affiliated Lecturer in the Department of Internal Medicine at the University of the Free State, addressed some commonly raised concerns about the COVID-19 vaccine and how it affects us.

Dr Potgieter started off by saying that coronaviruses have been causing outbreaks among humans for millennia. While COVID-19 is relatively mild and self-limiting in 80% of patients, 20% of patients are at risk of developing severe disease.
She said before a vaccine could be introduced to a population, it had to go through rigorous testing and clinical trials. Only once safety has been confirmed, it can be released and distributed. 

“This process usually takes about ten years; this is what we are used to. But it has happened much quicker for the COVID-19 vaccine, and I think this is a fact that many people misinterpret – that the evidence might not be that robust, which is certainly not the case. COVID-19 vaccines have gone through all this rigorous testing, thousands of patients had volunteered for trial testing studies. The point is that we already had the technology, vaccination is not something new to humans. So, these preclinical trials were able to happen very quickly, and because of the large number of infections and because the focus of the entire world was on finding a cure, it was a very set process to get these trials through the adequate phases.” 

She said the COVID-19 vaccine was approved by national regulators, manufactured to exacting standards, and only thereafter distributed – as is the case for all drugs released into the market.

How does the vaccine work?

Dr Potgieter said the vaccine works by producing antibodies against the COVID-19 virus. If you are infected with the COVID-19 virus after getting vaccinated, these antibodies bind to the virus and stop it from replicating.

“When you get infected with a disease such as COVID-19, natural antibodies are produced by the immune system to fight the disease. If you get infected again, the immune system will remember how to respond, and quickly destroy the virus. A vaccine can do the same, but without the risk of disease from natural infection. Vaccines work by imitating a bacteria or virus using either mRNA in the case of the COVID-19 vaccine, or a dead or weakened version of the bacteria or virus. The vaccine raises the body’s alarm. It trains the body to recognise and fight the virus. When the body encounters the real-deal virus, it is primed and ready to fight for the body’s health.”

She said South Africa had the mRNA vaccine in the form of the Pfizer vaccine, and the adenoviral vector vaccine in the form of the Johnson & Johnson vaccine.

Why should you get the vaccine?

Dr Potgieter said vaccines are safe and effective, and the most compelling reasons for getting vaccinated are the following:

-To protect yourself from severe disease
-To protect those around you who may be at risk of severe disease
-To restore the social and economic platforms of the country, and the world at large.
She said that while the vaccine does not prevent you from getting COVID-19, it offers better protection against the development of severe disease, and vaccinated people had 50% less chance of spreading the virus.
The most common side effects of the vaccine are the following:
-Pain at the injection site
-Swollen lymph nodes
-Fever
-Fatigue
-Headache
-Myalgia (muscle pain)

“These are indications that the immune system is mounting a response. When it mounts a response, it produces antibodies,” she said.

Answers to commonly asked questions are the following:

1. Can the vaccine alter my DNA?
“No, it goes nowhere near the nucleus of the cell.”

2. What happens when you get COVID in between the first and second doses?
“Some protection is conferred after the first dose, but maximum protection is conferred two weeks after the second dose. Vaccination is still advised.” 

Dr Potgieter said patients who were between vaccinations still show better recovery results than those without.

3. What about natural immunity?
“Natural immunity might confer better protection, but it runs the risk of severe disease. Yes, immunity can be gained through natural immunity, it can be gained through vaccination, and it can certainly be gained by a combination of the two.”

4. What about long-term side effects?
“Serious side effects that cause long-term health problems following any vaccination are very rare, including the COVID-19 vaccination.”

To get the answers to more of your questions, the webinar can be accessed via the following link: https://event.webinarjam.com/go/replay/43/053q6a8vay9a0qa2

News Archive

UFS School of Nursing opens new frontiers at 40
2009-11-16

The opening of the virtual facility of the School of Nursing at the University of the Free State (UFS) and a gala dinner to celebrate the School’s 40th year of existence took place on the Main Campus in Bloemfontein this week. At the opening were, among others, from the left: Prof. Jonathan Jansen, Rector and Vice-Chancellor of the UFS; Dr Oluseyi Oyedele and Ms Viona Munjeri, both from The Atlantic Philanthropies; and Prof. Anita van der Merwe, Head of the School of Nursing at the UFS.
Photo: Leatitia Pienaar

All eyes in the nursing profession in South Africa were turned to the University of the Free State (UFS) when the School of Nursing opened a state-of-the-art virtual health training and learning facility and celebrated its 40th year of existence with a gala dinner on the Main Campus in Bloemfontein this week.

The lustrous events were attended by dignitaries from all spheres of the health-care fraternity in South Africa.

The new virtual facility, The Space, is made possible by a grant of R16 million from The Atlantic Philanthropies and R1 million from the UFS. The Atlantic Philanthropies organisation is an international philanthropic organisation that is going to inject R70 million into nursing in South African over the next four years. The initiative will enhance nursing education and step up the quality of health-care delivery in South Africa. Four major grants were made to universities in South Africa, of which the UFS is one.

With the facility at the UFS School of Nursing, nursing education is propelled into the future. Prof. Anita van der Merwe, Head of the School of Nursing, says, “The virtual learning facility is a very new way of thinking and teaching. At the moment, theory and practice are separated, as theory is often taught in the mornings, followed by practical settings later in the day. Learner nurses then also go to clinical facilities for their practicals where the quality of care is declining and human resources are a problem.

“We believe that with new technologies such as e-learning and high-tech computer-mediated equipment we can use the ‘virtual world’ to bridge the theory-practice gap in the same location.”

Prof. Van der Merwe says the project is essentially about transformation: taking a stand against stagnation in nursing education and practice and daring to be different.

In the new virtual facility nurses will have the best of three worlds – the expertise of the facilitator/educator, simulation technology, and a vast selection of on-line and off-line software, exposing them to blogs, broadcasting and enhancing computer literacy. This will attract both the new “millennial” generation, which tends to be technologically competent, as well as the older learner because of the unthreatening learning environment.

The core space will accommodate 40 to 60 students and is designed to encourage informal, collaborative learning and practice simultaneously. It will have a demarcated area for “patients” (such as advanced adult and baby patient simulators) and a “clinic space” allowing for role play.

At the gala dinner, Prof. Jonathan Jansen, Rector and Vice-Chancellor of the UFS commended nurses in South Africa for their caring role, but also expressed his concern that South African has lost its deep sense of care. South Africa is at a critical point and the country can be changed if a deep sense of care can be embedded again.

About forty nursing educators from all over South Africa attended an exploratory workshop in the facility today and the last meeting of the Forum of University Deans in South Africa (FUNDISA) also coincided with the festivities at the School of Nursing.

Media Release
Issued by: Lacea Loader
Assistant Director: Media Liaison
Tel: 051 401 2584
Cell: 083 645 2454
E-mail: loaderl.stg@ufs.ac.za
13 November 2009
 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept